$ENDP At $5.86, Is Endo International plc (NASDAQ:

$ENDP At $5.86, Is Endo International plc (NASDAQ:ENDP) A Buy?



Endo International plc (NASDAQ:ENDP), a pharmaceuticals company based in Ireland, received a lot of attention from a substantial price movement on the NasdaqGS in the over the last few months, increasing to $8.86 at one point, and dropping to the lows of $5.86. This high level of volatility gives investors the opportunity to enter into the stock, and potentially buy at an artificially low price. A question to answer is whether Endo International’s current trading price of $5.86 reflective of the actual value of the small-cap? Or is it currently undervalued, providing us with the opportunity to buy? Let’s take a look at Endo International’s outlook and value based on the most recent financial data to see if there are any catalysts for a price change. View our latest analysis for Endo International

What’s the opportunity in Endo International?

Great news for investors – Endo International is still trading at a fairly cheap price. My valuation model shows that the intrinsic value for the stock is $25.4, but it is currently trading at US$5.86 on the share market, meaning that there is still an opportunity to buy now. Endo International’s share price also seems relatively stable compared to the rest of the market, as indicated by its low beta. If you believe the share price should eventually reach its true value, a low beta could suggest it is unlikely to rapidly do so anytime soon, and once it’s there, it may be hard to fall back down into an attractive buying range.

What kind of growth will Endo International generate?



Investors looking for growth in their portfolio may want to consider the prospects of a company before buying its shares. Although value investors would argue that it’s the intrinsic value relative to the price that matter the most, a more compelling investment thesis would be high growth potential at a cheap price. With profit expected to grow by 95.30% over the next couple of years, the future seems bright for Endo International. It looks like higher cash flows is on the cards for the stock, which should feed into a higher share valuation.

What this means for you:

Are you a shareholder? Since ENDP is currently undervalued, it may be a great time to accumulate more of your holdings in the stock. With a positive outlook on the horizon, it seems like this growth has not yet been fully factored into the share price. However, there are also other factors such as financial health to consider, which could explain the current undervaluation.

Are you a potential investor?

If you’ve been keeping an eye on ENDP for a while, now might be the time to enter the stock. Its buoyant future outlook isn’t fully reflected in the current share price yet, which means it’s not too late to buy ENDP. But before you make any investment decisions, consider other factors such as the strength of its balance sheet, in order to make a well-informed buy.

Price is just the tip of the iceberg. Dig deeper into what truly matters – the fundamentals – before you make a decision on Endo International. You can find everything you need to know about Endo International in the latest infographic research report. If you are no longer interested in Endo International, you can use our free platform to see my list of over 50 other stocks with a high growth potential.